At MNGI Digestive Health, patient well-being comes first. That promise is why the practice is not only a nationally ...

Researchers at the University of Chicago have discovered how the body defends itself against pancreatitis at the cellular ...

Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumors will be ...

A new study on a groundbreaking pancreatic cancer drug finds that it has the potential to double survival rates for more than ...

An experimental drug that could be a breakthrough in the treatment of one of the deadliest known cancers is driving demand at clinics while awaiting full government approval. Daraxonrasib, a drug that ...

A triple-targeted preclinical therapy combining daraxonrasib, afatinib, and SD36 drove durable pancreatic cancer regression ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of ...

The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic cancer Getty Daraxonrasib targets a previously untreatable protein in ...

Exclusive: People from deprived and minority ethnic backgrounds have better access to device than for previous technologies The rollout of a “life-changing” artificial pancreas on the NHS for people ...

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our ...

Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events, ...